Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults
Subtitle: a systematic review and economic evaluation
By: C. Green ... [et al.].
Contributors: Green, C.; National Co-ordinating Centre for HTA (Great Britain)
Series: Health technology assessment -- v. 9, no. 11
Publisher: Gray Publishing
Published: 2005
Place of publication: Tunbridge Wells
Language: eng
Number of pages: 140
Notes: 'NHS R&D HTA Programme' -Cover.